Medmira Stock Analysis

MedMira Pink Sheet Analysis Notes

About 70.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.0. MedMira had not issued any dividends in recent years. MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Latin America, the Caribbean, Europe, the Asia Pacific, and internationally. The company was founded in 1993 and is headquartered in Halifax, Canada. Medmira operates under Biotechnology classification in the United States and is traded on OTC Exchange.The quote for MedMira is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about MedMira contact Hermes Chan at 902 450 1588 or learn more at https://www.medmira.com.

MedMira Investment Alerts

MedMira Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 77.78 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MedMira's market, we take the total number of its shares issued and multiply it by MedMira's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

MedMira Profitablity

The company has Profit Margin (PM) of (2.27) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.79) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.79.

Technical Drivers

As of the 23rd of November, MedMira secures the Mean Deviation of 9.99, risk adjusted performance of 0.1078, and Standard Deviation of 39.27. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of MedMira, as well as the relationship between them. Please verify MedMira mean deviation, total risk alpha, as well as the relationship between the Total Risk Alpha and skewness to decide if MedMira is priced some-what accurately, providing market reflects its recent price of 0.0574 per share. As MedMira appears to be a penny stock we also strongly suggest to check its jensen alpha numbers.

MedMira Price Movement Analysis

MedMira Outstanding Bonds

MedMira Predictive Daily Indicators

MedMira Forecast Models

MedMira's time-series forecasting models are one of many MedMira's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary MedMira's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how MedMira prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling MedMira shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as MedMira. By using and applying MedMira Pink Sheet analysis, traders can create a robust methodology for identifying MedMira entry and exit points for their positions.

When running MedMira's price analysis, check to measure MedMira's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedMira is operating at the current time. Most of MedMira's value examination focuses on studying past and present price action to predict the probability of MedMira's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedMira's price. Additionally, you may evaluate how the addition of MedMira to your portfolios can decrease your overall portfolio volatility.